Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency

Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency

IntroductionHeadache and migraine adverse events are common concerns in the administration of intravenous immune globulins (IVIG). Trials of IVIG for primary immunodeficiency (PI) are typically small and have reported headache and migraine data inconsistently.MethodsWe analyzed headache and migraine...

Full description

Bibliographic Details
Main Authors: Bob Geng, Kim Clark, Mark Evangelista, Eric Wolford
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
IVIg
headache
migraine
primary immunodeficiency
rate escalation
pooled
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1075527/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1075527/full

Similar Items